Izrael -
hebrejščina -
Ministry of Health
אלפא די 3 0.5 מקג
teva pharmaceutical industries ltd, israel - alfacalcidol - קפסולות ג'לטין רכות - alfacalcidol 0.5 mcg
Izrael -
hebrejščina -
Ministry of Health
בינוקריט 8000 יחבל 0.8 מל
novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 8000 iu / 0.8 ml - erythropoietin
Izrael -
hebrejščina -
Ministry of Health
וסנואיד
tzamal bio-pharma ltd - tretinoin - קפסולות - tretinoin 10 mg - tretinoin
Izrael -
hebrejščina -
Ministry of Health
קיורטן 40 מג
taro international ltd, israel - isotretinoin - קפסולות ג'לטין רכות - isotretinoin 40 mg - isotretinoin
Izrael -
hebrejščina -
Ministry of Health
קיורטן 5 מג
taro international ltd, israel - isotretinoin - קפסולות ג'לטין רכות - isotretinoin 5 mg - isotretinoin
Izrael -
hebrejščina -
Ministry of Health
קפסיטבין תרו 500 מג
taro international ltd, israel - capecitabine - טבליות מצופות פילם - capecitabine 500 mg - capecitabine
Izrael -
hebrejščina -
Ministry of Health
קיורטן 30 מג
taro international ltd, israel - isotretinoin - קפסולות ג'לטין רכות - isotretinoin 30 mg - isotretinoin
Izrael -
hebrejščina -
Ministry of Health
קיורטן 30 מג
taro international ltd, israel - isotretinoin - קפסולות ג'לטין רכות - isotretinoin 30 mg - isotretinoin
Izrael -
hebrejščina -
Ministry of Health
רקורמון iu 5000
roche pharmaceuticals (israel) ltd - epoetin beta - תמיסה להזרקה - epoetin beta 5000 iu / 0.3 ml - erythropoietin - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative
Izrael -
hebrejščina -
Ministry of Health
רקורמון 10000 iu
roche pharmaceuticals (israel) ltd - epoetin beta - תמיסה להזרקה - epoetin beta 10000 iu / 0.6 ml - erythropoietin - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with chemotherapy. treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative erythropoietin deficiency* and are receiving anti-tumor therapy. * deficiency is defined as an